These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 25006236)

  • 1. Five year results of an international proficiency testing programme for measurement of antifungal drug concentrations.
    Lempers VJ; Alffenaar JW; Touw DJ; Burger DM; Uges DR; Aarnoutse RE; Brüggemann RJ
    J Antimicrob Chemother; 2014 Nov; 69(11):2988-94. PubMed ID: 25006236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The International Interlaboratory Quality Control Program for Measurement of Antiretroviral Drugs in Plasma: a global proficiency testing program.
    Burger D; Teulen M; Eerland J; Harteveld A; Aarnoutse R; Touw D
    Ther Drug Monit; 2011 Apr; 33(2):239-43. PubMed ID: 21383652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A rapid UPLC-MS/MS assay for the simultaneous measurement of fluconazole, voriconazole, posaconazole, itraconazole, and hydroxyitraconazole concentrations in serum.
    Basu SS; Petrides A; Mason DS; Jarolim P
    Clin Chem Lab Med; 2017 May; 55(6):836-844. PubMed ID: 27866173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality assurance program for pharmacokinetic assay of antiretrovirals: ACTG proficiency testing for pediatric and adult pharmacology support laboratories, 2003 to 2004: a requirement for therapeutic drug monitoring.
    Holland DT; DiFrancesco R; Connor JD; Morse GD
    Ther Drug Monit; 2006 Jun; 28(3):367-74. PubMed ID: 16778721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Poor performance of laboratories assaying newly developed antiretroviral agents: results for darunavir, etravirine, and raltegravir from the international quality control program for therapeutic drug monitoring of antiretroviral drugs in human plasma/serum.
    Burger D; Krens S; Robijns K; Aarnoutse R; Brüggemann R; Touw D
    Ther Drug Monit; 2014 Dec; 36(6):824-7. PubMed ID: 24819970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. International interlaboratory proficiency testing program for measurement of azole antifungal plasma concentrations.
    Brüggemann RJ; Touw DJ; Aarnoutse RE; Verweij PE; Burger DM
    Antimicrob Agents Chemother; 2009 Jan; 53(1):303-5. PubMed ID: 19015363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measurement of posaconazole, itraconazole, and hydroxyitraconazole in plasma/serum by high-performance liquid chromatography with fluorescence detection.
    Buckner SL; Ceesay MM; Pagliuca A; Morgan PE; Flanagan RJ
    Ther Drug Monit; 2011 Dec; 33(6):735-41. PubMed ID: 22105591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Candida and candidaemia. Susceptibility and epidemiology.
    Arendrup MC
    Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. International and multicenter comparison of EUCAST and CLSI M27-A2 broth microdilution methods for testing susceptibilities of Candida spp. to fluconazole, itraconazole, posaconazole, and voriconazole.
    Espinel-Ingroff A; Barchiesi F; Cuenca-Estrella M; Pfaller MA; Rinaldi M; Rodriguez-Tudela JL; Verweij PE
    J Clin Microbiol; 2005 Aug; 43(8):3884-9. PubMed ID: 16081926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multicentre determination of quality control strains and quality control ranges for antifungal susceptibility testing of yeasts and filamentous fungi using the methods of the Antifungal Susceptibility Testing Subcommittee of the European Committee on Antimicrobial Susceptibility Testing (AFST-EUCAST).
    Cuenca-Estrella M; Arendrup MC; Chryssanthou E; Dannaoui E; Lass-Florl C; Sandven P; Velegraki A; Rodriguez-Tudela JL;
    Clin Microbiol Infect; 2007 Oct; 13(10):1018-22. PubMed ID: 17697001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of EUCAST and CLSI broth microdilution methods for the susceptibility testing of 10 systemically active antifungal agents when tested against Candida spp.
    Pfaller MA; Castanheira M; Messer SA; Rhomberg PR; Jones RN
    Diagn Microbiol Infect Dis; 2014 Jun; 79(2):198-204. PubMed ID: 24736096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative evaluation of Sensititre YeastOne vs. the NCCLS M27A protocol and E-test for antifungal susceptibility testing of yeasts.
    Lombardi G; Farina C; Andreoni S; Fazii P; Faggi E; Pini G; Manso E; Nanetti A; Mazzoni A
    Mycoses; 2004 Oct; 47(9-10):397-401. PubMed ID: 15504123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Susceptibility testing of Cryptococcus diffluens against amphotericin B, flucytosine, fluconazole, itraconazole, voriconazole and posaconazole.
    Kantarcioğlu AS; Boekhout T; Yücel A; Altas K
    Med Mycol; 2009 Mar; 47(2):169-76. PubMed ID: 18654925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of fluconazole as a surrogate marker to predict susceptibility and resistance to voriconazole among 13,338 clinical isolates of Candida spp. Tested by clinical and laboratory standards institute-recommended broth microdilution methods.
    Pfaller MA; Messer SA; Boyken L; Rice C; Tendolkar S; Hollis RJ; Diekema DJ
    J Clin Microbiol; 2007 Jan; 45(1):70-5. PubMed ID: 17079501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Explaining and reducing the variation in inter-laboratory reported values for International Normalised Ratio.
    Bonar R; Favaloro EJ
    Thromb Res; 2017 Feb; 150():22-29. PubMed ID: 27998809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analytical performances of food microbiology laboratories - critical analysis of 7 years of proficiency testing results.
    Abdel Massih M; Planchon V; Polet M; Dierick K; Mahillon J
    J Appl Microbiol; 2016 Feb; 120(2):346-54. PubMed ID: 26599261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Educational antimicrobial susceptibility testing as a critical component of microbiology laboratory proficiency programs: American Proficiency Institute results for 2007-2011.
    Jones RN; Glick T; Sader HS; Flamm RK; Ross JE; Rhomberg PR; Edson DC
    Diagn Microbiol Infect Dis; 2013 Apr; 75(4):357-60. PubMed ID: 23481025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of visual 24-hour and spectrophotometric 48-hour MICs to CLSI reference microdilution MICs of fluconazole, itraconazole, posaconazole, and voriconazole for Candida spp.: a collaborative study.
    Espinel-Ingroff A; Barchiesi F; Cuenca-Estrella M; Fothergill A; Pfaller MA; Rinaldi M; Rodriguez-Tudela JL; Verweij PE
    J Clin Microbiol; 2005 Sep; 43(9):4535-40. PubMed ID: 16145103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of Voriconazole Concentrations in Serum by GC-MS.
    Smith A; Leung-Pineda V
    J Clin Lab Anal; 2016 Sep; 30(5):411-7. PubMed ID: 26351082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antifungal susceptibility testing method for resource constrained laboratories.
    Khan S; Singhal S; Mathur T; Upadhyay DJ; Rattan A
    Indian J Med Microbiol; 2006 Jul; 24(3):171-6. PubMed ID: 16912435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.